Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcutis Biotherapeutics (ARQT) Total Current Liabilities (2020 - 2025)

Arcutis Biotherapeutics has reported Total Current Liabilities over the past 6 years, most recently at $129.8 million for Q4 2025.

  • Quarterly results put Total Current Liabilities at $129.8 million for Q4 2025, up 60.27% from a year ago — trailing twelve months through Dec 2025 was $129.8 million (up 60.27% YoY), and the annual figure for FY2025 was $129.8 million, up 60.27%.
  • Total Current Liabilities for Q4 2025 was $129.8 million at Arcutis Biotherapeutics, up from $99.8 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for ARQT hit a ceiling of $172.4 million in Q3 2024 and a floor of $13.3 million in Q2 2021.
  • Median Total Current Liabilities over the past 5 years was $39.8 million (2022), compared with a mean of $57.8 million.
  • Biggest five-year swings in Total Current Liabilities: skyrocketed 311.63% in 2024 and later plummeted 42.14% in 2025.
  • Arcutis Biotherapeutics' Total Current Liabilities stood at $33.3 million in 2021, then rose by 13.45% to $37.8 million in 2022, then grew by 23.44% to $46.7 million in 2023, then soared by 73.59% to $81.0 million in 2024, then soared by 60.27% to $129.8 million in 2025.
  • The last three reported values for Total Current Liabilities were $129.8 million (Q4 2025), $99.8 million (Q3 2025), and $103.9 million (Q2 2025) per Business Quant data.